Immune Response to FVIII in Hemophilia A: An Overview of Risk Factors
- 17 January 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Reviews in Allergy & Immunology
- Vol. 37 (2), 58-66
- https://doi.org/10.1007/s12016-009-8118-1
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutationsHaemophilia, 2008
- A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levelsBlood, 2007
- High-dose factor VIII inhibits factor VIII–specific memory B cells in hemophilia A with factor VIII inhibitorsBlood, 2005
- The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99Journal of Thrombosis and Haemostasis, 2004
- Inhibitors against factor VIII in patients with cancerCancer, 2001
- Postpartum Acquired Hemophilia (Factor VIII Inhibitors): A Case Report and Review of the LiteratureObstetrical & Gynecological Survey, 2000
- Surgery-Associated Factor VIII Inhibitors in Patients without HemophiliaThe American Journal of the Medical Sciences, 1999
- Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitorEuropean Journal of Haematology, 1997
- Simultaneous occurrence of factor VIIIC inhibitor and lupus anticoagulantAmerican Journal of Hematology, 1993
- A study of cell mediated and humoral immunity in haemophilia and related disordersBritish Journal of Haematology, 1985